Respiratory Medicine
Volume 97, Issue 1 , Pages 12-19 , January 2003

Improvement of asthma control with a breath-actuated pressurised metred dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metred dose inhaler (MDI) or a breath-actuated device

  • D. PRICE

      Affiliations

    • Department of General Practice and Primary Care, University of Aberdeen, Aberdeen, AB25 2AY, U.K.
    • Correspondence should be addressed to: David Price, General Practice Airways Group Professor of Primary Care Respiratory Medicine, Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen AB25 2AY, U.K. Fax: +44 1224 550683; E-mail: d.price@abdn.ac.uk
    • ,
  • M. THOMAS

      Affiliations

    • Department of General Practice and Primary Care, University of Aberdeen, Aberdeen, AB25 2AY, U.K.
    • ,
  • G. MITCHELL

      Affiliations

    • Abacus International, Bicester, Oxon, U.K.
    • ,
  • C. NIZIOL

      Affiliations

    • Abacus International, Bicester, Oxon, U.K.
    • ,
  • R. FEATHERSTONE

      Affiliations

    • IVAX Pharmaceuticals UK Ltd. Albert Basin, Royal Docks, London, U.K.

Received 1 March 2002 ,Accepted 3 July 2002.

References 

    REFERENCES
  1. Asthma J. 2001;6:
  2. Price DB, Ryan D, Pearce L. The AIR study. Asthma J. 1999;4:74–78
  3. Rabe KF, Vermeire PA, Soriano JB. Clinical management of asthma in 1999: the Asthma Insights and Reality Europe (AIRE) study. Eur Respir. 2000;16:802–807
  4. Morice AH. The role of the asthma nurse in treatment compliance and self-management following hospital admission. Respir Med. 2001;95:851–856
  5. Ward M. Asthma education-where now?. Respir Med. 2001;95:849–850
  6. Bousquet J. Global initiative for asthma (GINA) and its objectives. Clin Exp Allergy. 2000;30:2–5
  7. Von Mutius E. Presentation of new GINA guidelines for paediatrics. The Global Initiative on Asthma. Clin Exp Allergy. 2000;30:6–10
  8. Thorax. 1997;52:S2
  9. Milgrom H, Bender B. Nonadherence to asthma treatment and failure of therapy. Curr Opin Pediatr. 1997;9:590–595
  10. Milgrom H, Bender B, Ackerson L. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol. 1996;98:1051–1057
  11. Roche N, Huchon G. Rationale for the choice of an aerosol delivery system. J Aerosol Med. 2000;13:393–404
  12. Osman LM, Friend JA, Legge JS. Requests for repeat medication prescriptions and frequency of acute episodes in asthma patients. J Asthma. 1999;36:449–457
  13. Cimas JE, Arce MC, Gonzalez ME. Factors related with the morbidity of asthma. Broncopneumology. 1997;33:389–394
  14. Gonda I, Schuster JA, Rubsamen RM. Inhalation delivery systems with compliance and disease management capabilities. J Control release. 1998;30:269–274
  15. Lahdensuo A, Muittari A. Bronchodilator effects of a fenoterol metered dose inhaler and fenoterol powder in asthmatics with poor inhaler technique. Eur J Respir Dis. 1986;68:332–335
  16. Lindgren D, Blake B, Larrson S. Clinical consequences of inadequate inhalation technique in asthma. Eur J Respir Dis. 1987;70:93–98
  17. Newman SP. Aerosol deposition considerations in inhalation therapy. Chest. 1985;88:152s–160s
  18. Hoskins G, McGowan C, Neville R. Risk factors and costs associated with an asthma attack. Thorax. 2000;24–55
  19. Duerden M, Price D. Training issues in the use of inhalers. Dis Manage Health Outcomes. 2001;9:75–87
  20. Shrestha M, Parupia H, Andrews B. Metered dose inhaler technique of patients in an urban ED: prevalence of incorrect technique and attempt at education. Am J Emerg Med. 1996;14:380–384
  21. Kamps AW, Van Ewijk B, Roorda RJ. Poor inhalation technique even after inhalation instructions, in children with asthma. Pediatric Pulmonol. 2000;29:39–42
  22. Newman SP. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax. 1991;46:712–726
  23. Zanon P. Inhalation anti-asthma therapy with spacers:technical aspects. Monaldi Arch Chest Dis. 1994;49:258–264
  24. George M. A comprehensive educational program improves clinical outcome measures in inner-city patients with asthma. Arch Intern Med. 1999;159:1710–1716
  25. Brocklebank D, Ram F, Wright J. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5:
  26. Brocklebank D, Wright J, Cates C. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma. BMJ. 2001;323:901–911
  27. Ram F, Wright J, Brocklebank D. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering B2 agonists bronchodilators in asthma. BMJ. 2001;323:896–900
  28. Lipworth BJ. Patients can't use pMDI's in real life. BMJ Online. October 2001;21:
  29. Williams I. Cheapest is best?. BMJ online. 2001, 25 October;
  30. Senn S. Meta-analysis: more stress on analysis please. BMJ Online. 2001, October 27;
  31. Price DB, Pearce L, Powell SR. Handling and acceptability of the Easi-Breathe device compared with a conventional metered dose inhaler by patients and practice nurses. Int J Clin Practice. 1999;53:31–36
  32. Lenney J, Innes A, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med. 2000;94:496–500
  33. Chapman KR, Love L, Brubaker HA. Comparison of BAI's and conventional metered dose inhalation rechniques in elderly subjects. Chest. 1993;104:1332–1337
  34. Hampson NB, Mueller MP. Reduction in patient timing errors using a breath-activated metered dose inhaler. Chest. 1994;106:462–465
  35. Hilton S. An audit of inhaler technique among asthma patients of 34 general practitioners. Br J Gen Pract. 1990;40:505–506
  36. Hendry A, Coote J, Black H. Comparison of conventional metered dose inhaler with breath actuated metered dose inhaler in elderly patients. Int J Clin Pract. 1995;3:115–118
  37. Reesor Nimmo CJ. Assessment of patients acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-actuated devices. Ann Pharmacother. 1993;27:922–927
  38. Campbell LM. A comparison of the efficacy of long-acting a2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Res Med. 1999;93:224–236
  39. DIN-Link database, Compufile Ltd. www.compufile.co.uk
  40. Warner JO. Review of prescribed treatment for children with asthma in 1990. BMJ. 1995;311:663–666
  41. ACORN scoring system, CACI ltd. www.caci.co.uk
  42. Garrett J, Turner P. The severity of asthma in relation to beta agonist prescribing. N Z Med J. 1991;104:39–40
  43. Fayon M, Just J, Thien H. Bacterial flora of the lower respiratory tract in children with bronchial asthma. Acta Paediatr. 1999;88:1216–1222
  44. Glezen WP, Greenberg SB, Atmar RL. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283:499–505
  45. Paramesh H. Practical approach to recurrent respiratory infections. Indian J Pediatr. 1996;63:181–187
  46. LAIA, Prevalence of asthma treated in general practice, Lung and Asthma Information Agency factsheet 99/1, www.sghms.ac.uk, 1999

PII: S0954-6111(02)91426-5

doi: 10.1053/rmed.2002.1426

Respiratory Medicine
Volume 97, Issue 1 , Pages 12-19 , January 2003

Article Tools